BioLight Life Sciences Ltd. (TLV:BOLT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
235.50
-5.60 (-2.32%)
Apr 28, 2026, 5:24 PM IDT
-63.32%
Market Cap 21.81M
Revenue (ttm) n/a
Net Income (ttm) -11.73M
Shares Out 9.05M
EPS (ttm) -1.98
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,463
Average Volume 43,901
Open 241.10
Previous Close 241.10
Day's Range 234.70 - 241.10
52-Week Range 209.20 - 636.70
Beta 0.37
RSI 40.68
Earnings Date Apr 6, 2026

About BioLight Life Sciences

BioLight Life Sciences Ltd. engages in the investment, development, management, and commercialization of products in the fields of advanced medical devices, pharmaceuticals, diagnostics, and digital medicine in Israel. The company offers TeaRx, a diagnostic platform intended for point-of-care testing of ophthalmic pathologies through multi-parameter composition analysis of the tear fluid; TeaRx Dry Eye Syndrome; and Ocuvia, a front-to-back ocular treatment that includes ocudrip and ocugrid. It also provides Eye-D technology which treats glaucom... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 4
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BOLT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.